Moreover, AMPK and its regulated genes including SREBP and ChREBP were involved in the regulation of metabolic disorders such as hyperglycemia, hypercholesterolemia, hyeruricemia that is associated with kidney diseases, cardiovascular disease, and NAFLD. This evidence concerns the gene MLXIPL and metabolic disease.